FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908269188> ?p ?o ?g. }

• W2908269188 abstract "In recognition of the threat of insecticide resistance in vectors of malaria, the WHO Global Malaria Programme recommends the development of an appropriate and comprehensive response to insecticide resistance. In principle, good resistance management practice requires the application of multiple insecticides of different modes of action, for example, in rotations and mixtures. Insecticides recommended by the World Health Organization for indoor residual spraying and long-lasting insecticide nets are limited. It is, therefore, judicious to prevent the rapid spread of insecticide resistance by evaluating new insecticides formulations with different modes of action and long residual effect.Fludora® Fusion, a new neonicotinoid IRS formulation (a mixture of 500 g/kg clothianidin and 62.5 g/kg deltamethrin applied 200 mg ai/sqm + 25 mg ai/sqm, respectively) was tested. Small scale field evaluation of this product was conducted in the district of Dangbo in Benin, to compare its efficacy and residual effect on cement and mud walls against those of clothianidin 200 mg ai/sqm (WG 70) alone, and of deltamethrin 25 mg ai/sqm (WG 250) alone. WHO wall cone bioassays were conducted monthly with laboratory susceptible Anopheles Kisumu and wild Anopheles gambiae sensu stricto (s.s.) population from Dangbo. The induced mortality by each treatment per wall substrate for 24 h, 48 h, and 72 h post exposure were recorded every month and analysed.Fludora® Fusion and clothianidin WG 70 showed mortality rates over 80% WHO bio-efficacy threshold on cement walls either with susceptible or resistant An. gambiae s.s. over a period of 10 and 9 months, respectively. Treatment with Fludora® Fusion and clothianidin WG 70 on the mud walls showed residual effect for 6 months and 5 months respectively against both susceptible and resistant mosquitoes. During the whole evaluation period, deltamethrin WG 250 showed mortality rates below 80% against resistant Anopheles population. Furthermore, the knock down rates observed with the Fludora® Fusion combination were significantly higher (p < 5%) than those induced by Clothiandin WG 70.Both the Fludora® Fusion combination and clothianidin alone showed very good and lasting efficacy for IRS against resistant Anopheles with some residual benefit provided by the combination. The residual efficacy of the Fludora® Fusion combination evaluated at 10 months shows this product is a good candidate for IRS interventions." @default.
• W2908269188 created "2019-01-11" @default.
• W2908269188 creator A5005983745 @default.
• W2908269188 creator A5017390012 @default.
• W2908269188 creator A5022507169 @default.
• W2908269188 creator A5033758629 @default.
• W2908269188 creator A5035871946 @default.
• W2908269188 creator A5044107991 @default.
• W2908269188 creator A5051491392 @default.
• W2908269188 creator A5054002927 @default.
• W2908269188 creator A5060492299 @default.
• W2908269188 creator A5065547847 @default.
• W2908269188 creator A5087480744 @default.
• W2908269188 date "2018-12-01" @default.
• W2908269188 modified "2023-10-12" @default.
• W2908269188 title "Small-scale field evaluation of the efficacy and residual effect of Fludora® Fusion (mixture of clothianidin and deltamethrin) against susceptible and resistant Anopheles gambiae populations from Benin, West Africa" @default.
• W2908269188 cites W1979663833 @default.
• W2908269188 cites W2021548927 @default.
• W2908269188 cites W2064261657 @default.
• W2908269188 cites W2097381571 @default.
• W2908269188 cites W2109676864 @default.
• W2908269188 cites W2109836863 @default.
• W2908269188 cites W2110205700 @default.
• W2908269188 cites W2111572642 @default.
• W2908269188 cites W2115226983 @default.
• W2908269188 cites W2115872828 @default.
• W2908269188 cites W2115907339 @default.
• W2908269188 cites W2120735153 @default.
• W2908269188 cites W2125437926 @default.
• W2908269188 cites W2136952555 @default.
• W2908269188 cites W2155767317 @default.
• W2908269188 cites W2157550937 @default.
• W2908269188 doi "https://doi.org/10.1186/s12936-018-2633-6" @default.
• W2908269188 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6311023" @default.
• W2908269188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30594207" @default.
• W2908269188 hasPublicationYear "2018" @default.
• W2908269188 type Work @default.
• W2908269188 sameAs 2908269188 @default.
• W2908269188 citedByCount "31" @default.
• W2908269188 countsByYear W29082691882019 @default.
• W2908269188 countsByYear W29082691882020 @default.
• W2908269188 countsByYear W29082691882021 @default.
• W2908269188 countsByYear W29082691882022 @default.
• W2908269188 countsByYear W29082691882023 @default.
• W2908269188 crossrefType "journal-article" @default.
• W2908269188 hasAuthorship W2908269188A5005983745 @default.
• W2908269188 hasAuthorship W2908269188A5017390012 @default.
• W2908269188 hasAuthorship W2908269188A5022507169 @default.
• W2908269188 hasAuthorship W2908269188A5033758629 @default.
• W2908269188 hasAuthorship W2908269188A5035871946 @default.
• W2908269188 hasAuthorship W2908269188A5044107991 @default.
• W2908269188 hasAuthorship W2908269188A5051491392 @default.
• W2908269188 hasAuthorship W2908269188A5054002927 @default.
• W2908269188 hasAuthorship W2908269188A5060492299 @default.
• W2908269188 hasAuthorship W2908269188A5065547847 @default.
• W2908269188 hasAuthorship W2908269188A5087480744 @default.
• W2908269188 hasBestOaLocation W29082691881 @default.
• W2908269188 hasConcept C161176658 @default.
• W2908269188 hasConcept C203014093 @default.
• W2908269188 hasConcept C2776120307 @default.
• W2908269188 hasConcept C2776784398 @default.
• W2908269188 hasConcept C2776802408 @default.
• W2908269188 hasConcept C2777553912 @default.
• W2908269188 hasConcept C2778048844 @default.
• W2908269188 hasConcept C2778371730 @default.
• W2908269188 hasConcept C2779070988 @default.
• W2908269188 hasConcept C2779915640 @default.
• W2908269188 hasConcept C2780346216 @default.
• W2908269188 hasConcept C2908647359 @default.
• W2908269188 hasConcept C33070731 @default.
• W2908269188 hasConcept C42972112 @default.
• W2908269188 hasConcept C6557445 @default.
• W2908269188 hasConcept C71924100 @default.
• W2908269188 hasConcept C86803240 @default.
• W2908269188 hasConcept C99454951 @default.
• W2908269188 hasConceptScore W2908269188C161176658 @default.
• W2908269188 hasConceptScore W2908269188C203014093 @default.
• W2908269188 hasConceptScore W2908269188C2776120307 @default.
• W2908269188 hasConceptScore W2908269188C2776784398 @default.
• W2908269188 hasConceptScore W2908269188C2776802408 @default.
• W2908269188 hasConceptScore W2908269188C2777553912 @default.
• W2908269188 hasConceptScore W2908269188C2778048844 @default.
• W2908269188 hasConceptScore W2908269188C2778371730 @default.
• W2908269188 hasConceptScore W2908269188C2779070988 @default.
• W2908269188 hasConceptScore W2908269188C2779915640 @default.
• W2908269188 hasConceptScore W2908269188C2780346216 @default.
• W2908269188 hasConceptScore W2908269188C2908647359 @default.
• W2908269188 hasConceptScore W2908269188C33070731 @default.
• W2908269188 hasConceptScore W2908269188C42972112 @default.
• W2908269188 hasConceptScore W2908269188C6557445 @default.
• W2908269188 hasConceptScore W2908269188C71924100 @default.
• W2908269188 hasConceptScore W2908269188C86803240 @default.
• W2908269188 hasConceptScore W2908269188C99454951 @default.
• W2908269188 hasIssue "1" @default.
• W2908269188 hasLocation W29082691881 @default.
• W2908269188 hasLocation W29082691882 @default.
• W2908269188 hasLocation W29082691883 @default.
• W2908269188 hasLocation W29082691884 @default.
• W2908269188 hasOpenAccess W2908269188 @default.
• W2908269188 hasPrimaryLocation W29082691881 @default.

• next